3-iodobenzylguanidine has been researched along with MEA 2b in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnous, MM; Lan, X; Sun, X | 1 |
Aoi, S; Fumino, S; Iwai, N; Shimotake, T; Tsuda, T | 1 |
Isobe, Y; Kihara, M; Kobayashi, S; Matsusaka, K; Miyauchi, A; Nishiyama, Y; Ohkawa, M; Takashima, H; Tanabe, M; Yamamoto, Y | 1 |
Chisin, R; Glaser, B; Guttmann, H; Ish-Shalom, S; Krausz, Y; Rosler, A; Shibley, N | 1 |
De Graaf, JS; Dullaart, RP; Kok, T; Piers, DA; Zwierstra, RP | 1 |
Bonjer, HJ; Boomsma, F; Bosman, FT; Bruining, HA; de Herder , WW; de Krijger , RR; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW; Stijnen, T; van de Meiracker , AH; van der Harst, E | 1 |
6 other study(ies) available for 3-iodobenzylguanidine and MEA 2b
Article | Year |
---|---|
Multiple Endocrine Neoplasia Type 2B Unmasked by 18 F-FDG PET/CT and 131 I-MIBG SPECT/CT.
Topics: 3-Iodobenzylguanidine; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Multiple Endocrine Neoplasia Type 2b; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Thyroid Neoplasms | 2017 |
Iodine 123 metaiodobenzylguanidine radio-guided navigation surgery for recurrent medullary thyroid carcinoma in a girl with multiple endocrine neoplasia type 2B.
Topics: 3-Iodobenzylguanidine; Adolescent; Carcinoma, Medullary; Child; Female; Follow-Up Studies; Humans; Multiple Endocrine Neoplasia Type 2b; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2005 |
Iodine-131 MIBG imaging in multiple endocrine neoplasia type 2B.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenal Medulla; Adrenalectomy; Carcinoma, Medullary; Humans; Hyperplasia; Iodine Radioisotopes; Lymphatic Metastasis; Male; Multiple Endocrine Neoplasia Type 2b; Neoplasm Staging; Pheochromocytoma; Precancerous Conditions; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 1998 |
Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Bone Neoplasms; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Medullary; Female; Follow-Up Studies; Humans; Indium Radioisotopes; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multiple Endocrine Neoplasia Type 2b; Octreotide; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed; Trachea | 1999 |
Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Algorithms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2000 |
[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Disease-Free Survival; Humans; Indium Radioisotopes; Iodine Radioisotopes; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Neoplasm Metastasis; Octreotide; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Retrospective Studies; Survival Rate; Tissue Distribution | 2001 |